Periscope Capital’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Periscope Capital’s Portfolio PEPLW Stock Details PEPLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-251,200	Closed	-$7.56K	–	478
2023 Q4	$7.56K	Hold	251,200	–	–	﹤0.01%	404
2023 Q3	$17.8K	Hold	251,200	–	–	﹤0.01%	479
2023 Q2	$5.71K	Hold	251,200	–	–	﹤0.01%	646
2023 Q1	$23.9K	Hold	251,200	–	–	﹤0.01%	633
2022 Q4	$2.9K	Hold	251,200	–	–	﹤0.01%	870
2022 Q3	$19K	Hold	251,200	–	–	﹤0.01%	894
2022 Q2	$52K	Hold	251,200	–	–	﹤0.01%	688
2022 Q1	$104K	Buy	+251,200	New	+$108K	﹤0.01%	752

Other funds holding PEPLW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Periscope Capital's PEPLW Position: Q1 2024 in Review

Periscope Capital sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q1 2024, closing a stake of 251,200 shares — an estimated $7.56K sold.

Periscope Capital first reported a position in PEPLW in Q1 2022 and held it in 8 quarters. The position peaked at $104K in Q1 2022. 1 fund tracked by Wall St. Rank holds PEPLW as of Q1 2024.

Periscope Capital reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q1 2024 after selling out during the quarter.
Periscope Capital sold 251,200 PepperLime Health Acquisition Corporation Warrrant shares in Q1 2024, an estimated $7.56K.
Periscope Capital first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q1 2022 and held it in 8 quarters.
Periscope Capital's PepperLime Health Acquisition Corporation Warrrant position peaked at $104K in Q1 2022.
1 fund tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q1 2024.

Based on Periscope Capital's 13F filing for Q1 2024, filed 13 May 2024.